Upgrade to SI Premium - Free Trial

Genmab A/S (GMAB) PT Raised to $54 at Guggenheim

October 5, 2026 6:23 AM
(Updated - October 5, 2026 6:24 AM EDT)

Guggenheim analyst Michael Schmidt raised the price target on Genmab A/S ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change